Evidence map›Paper›PMID 26013829›Full record

ArticleThe Journal of biological chemistry2015

Intra-domain Cross-talk Regulates Serine-arginine Protein Kinase 1-dependent Phosphorylation and Splicing Function of Transformer 2β1.

Michael A Jamros, Brandon E Aubol, Malik M Keshwani, Zhaiyi Zhang, Stefan Stamm, Joseph A Adams

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. The new (dis)order in RNA regulation.Cell communication and signaling : CCS · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael A JamrosFrom the Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636 and.
Brandon E AubolFrom the Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636 and.
Malik M KeshwaniFrom the Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636 and.
Zhaiyi Zhangthe Molecular and Cellular Biochemistry Department, University of Kentucky, Lexington, Kentucky 40536.
Stefan Stammthe Molecular and Cellular Biochemistry Department, University of Kentucky, Lexington, Kentucky 40536.
Joseph A AdamsFrom the Department of Pharmacology, University of California at San Diego, La Jolla, California 92093-0636 and j2adams@ucsd.edu.
University of California, San Diego · USUniversity of Kentucky · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Role of protein phosphorylation in RNA splicingR01GM067969 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2004 to 2024
$6.4M
NIGMS NIH HHS GM067969NIGMS NIH HHS R01 GM067969NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

Transformer 2β1 (Tra2β1) is a splicing effector protein composed of a core RNA recognition motif flanked by two arginine-serine-rich (RS) domains, RS1 and RS2. Although Tra2β1-dependent splicing is regulated by phosphorylation, very little is known about how protein kinases phosphorylate these two RS domains. We now show that the serine-arginine protein kinase-1 (SRPK1) is a regulator of Tra2β1 and promotes exon inclusion in the survival motor neuron gene 2 (SMN2). To understand how SRPK1 phosphorylates this splicing factor, we performed mass spectrometric and kinetic experiments. We found that SRPK1 specifically phosphorylates 21 serines in RS1, a process facilitated by a docking groove in the kinase domain. Although SRPK1 readily phosphorylates RS2 in a splice variant lacking the N-terminal RS domain (Tra2β3), RS1 blocks phosphorylation of these serines in the full-length Tra2β1. Thus, RS2 serves two new functions. First, RS2 positively regulates binding of the central RNA recognition motif to an exonic splicing enhancer sequence, a phenomenon reversed by SRPK1 phosphorylation on RS1. Second, RS2 enhances ligand exchange in the SRPK1 active site allowing highly efficient Tra2β1 phosphorylation. These studies demonstrate that SRPK1 is a regulator of Tra2β1 splicing function and that the individual RS domains engage in considerable cross-talk, assuming novel functions with regard to RNA binding, splicing, and SRPK1 catalysis.

Indexed as

Binding SitesExonsHEK293 CellsHumansKineticsMutagenesis, Site-DirectedNerve Tissue ProteinsPhosphorylationProtein Interaction Domains and MotifsProtein Serine-Threonine KinasesRecombinant ProteinsRNARNA-Binding ProteinsRNA SplicingSerineSerine-Arginine Splicing FactorsNerve Tissue ProteinsProtein Serine-Threonine KinasesRecombinant ProteinsRNARNA-Binding ProteinsSerineSerine-Arginine Splicing FactorsSMN2 protein, humanSRPK1 protein, humanSurvival of Motor Neuron 2 ProteinTRA2B protein, humanalternative splicingkineticsmass spectrometry (MS)protein kinaserapid quenchRNA

Identifiers

PMID26013829
PMCPMC4498066
OpenAlexW1553975437

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.